Create Medic Co., Ltd. AI Stock Analysis
Want to see JP:5187 full AI Analyst Report?
Create Medic Co., Ltd. (5187) AI Stock Analysis
Create Medic Co., Ltd.
(TSE/TYO:5187)
Create Medic Co., Ltd. presents a moderate investment profile. The most significant strengths are a fortress balance sheet with minimal leverage and an attractive 4.33% dividend yield. Conversely, bearish technical momentum across all moving averages and recent inefficiencies in cash flow generation present notable near-term risks.
Create Medic Co., Ltd. (5187) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 8.81B
- Dividend Yield
- 4.34%
- Average Volume (3M)
- 4,391
- Price to Earnings (P/E)
- 25.9
- Beta (1Y)
- 0.30
- Revenue Growth
- 3.38%
- EPS Growth
- -52.61%
- Country
- Japan
- Employees
- 1,010
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Specialties
Create Medic Co., Ltd. Business Overview & Revenue Model
Company Description
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, su...
How the Company Makes Money
Create Medic primarily makes money by selling medical devices and single-use medical consumables to healthcare providers (e.g., hospitals and clinics) through domestic and export distribution channels. Its core revenue comes from recurring demand for...
Create Medic Co., Ltd. Financial Statement Overview
Summary
The company maintains a pristine balance sheet with minimal debt and steady top-line growth. However, a sharp drop in operating cash flow and recent cash generation volatility weigh on an otherwise solid financial profile.
Income Statement
72PositiveBalance Sheet
90Very PositiveCash Flow
48Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.03B | 13.62B | 13.03B | 12.59B | 12.33B | 11.70B |
| Gross Profit | 5.71B | 5.99B | 5.70B | 5.48B | 5.37B | 5.26B |
| EBITDA | 1.21B | 1.64B | 1.73B | 1.50B | 1.47B | 1.43B |
| Net Income | 348.91M | 713.73M | 840.90M | 154.02M | 482.21M | 660.41M |
Balance Sheet | ||||||
| Total Assets | 19.83B | 20.14B | 20.05B | 19.26B | 19.12B | 18.08B |
| Cash, Cash Equivalents and Short-Term Investments | 5.49B | 5.83B | 6.32B | 4.39B | 4.31B | 4.36B |
| Total Debt | 749.70M | 749.70M | 891.96M | 884.78M | 933.42M | 815.36M |
| Total Liabilities | 3.68B | 3.81B | 4.30B | 4.31B | 4.40B | 3.86B |
| Stockholders Equity | 16.15B | 16.33B | 15.75B | 14.94B | 14.72B | 14.22B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 98.51M | 1.77B | 246.98M | 101.75M | 629.58M |
| Operating Cash Flow | 0 | 530.12M | 2.25B | 698.84M | 461.34M | 1.25B |
| Investing Cash Flow | 0 | -573.08M | 270.62M | -363.61M | 38.01M | -585.01M |
| Financing Cash Flow | 0 | -600.39M | -877.65M | -362.19M | -355.59M | -442.52M |
Create Medic Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5187, the sentiment is Negative. The current price of 1105.00 is below the 20-day moving average (MA) of 1106.55, below the 50-day MA of 1127.40, and below the 200-day MA of 1127.73, indicating a bearish trend. The MACD of -8.32 indicates Negative momentum. The RSI at 47.01 is Neutral, neither overbought nor oversold. The STOCH value of 55.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5187.
Create Medic Co., Ltd. Peers Comparison
Overall Rating
JP:667882Outperform
JP:684963Neutral
JP:518762Neutral
JP:652361Neutral
JP:454950Neutral
JP:760045Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | JPY 18.29B | 12.27 | ― | 6.01% | 17.11% | 23.02% | |
| 63Neutral | JPY 254.11B | 20.98 | ― | 2.06% | -0.18% | -33.38% | |
| 62Neutral | JPY 10.05B | 25.90 | ― | 4.34% | 3.38% | -52.61% | |
| 61Neutral | JPY 165.53B | 11.48 | 8.71% | 3.23% | 2.74% | 145.33% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 50Neutral | JPY 73.85B | 39.86 | ― | 2.59% | 3.92% | -52.01% | |
| 45Neutral | JPY 8.06B | -5.18 | ― | 5.56% | -8.68% | -75.03% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:5187 | Create Medic Co., Ltd. | 1105.00 | 150.20 | 15.73% | |
| JP:6523 | PHC Holdings Corp. | 1300.00 | 374.19 | 40.42% | |
| JP:4549 | Eiken Chemical Co., Ltd. | 2240.00 | 37.76 | 1.71% | |
| JP:6678 | Techno Medica Co., Ltd. | 2146.00 | 271.73 | 14.50% | |
| JP:6849 | Nihon Kohden Corporation | 1550.00 | 20.56 | 1.34% | |
| JP:7600 | Japan Medical Dynamic Marketing, Inc. | 306.00 | -165.73 | -35.13% |
Create Medic Co., Ltd. Corporate Events
Create Medic Sales Rise as Nine-Month Profit Plunges
Create Medic reported nine-month net sales of ¥10.467 billion for the period ended September 30, 2026, up 4.1% year on year. Operating profit fell 44.2% to ¥509 million, ordinary profit declined 34.8% to ¥568 million, and profit attributable to owner...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
